35.90
-0.73(-1.99%)
Currency In USD
| Previous Close | 36.63 |
| Open | 36.95 |
| Day High | 37.04 |
| Day Low | 35.87 |
| 52-Week High | 61.27 |
| 52-Week Low | 29.31 |
| Volume | 945,303 |
| Average Volume | 1.73M |
| Market Cap | 4.29B |
| PE | -6.79 |
| EPS | -5.29 |
| Moving Average 50 Days | 34.01 |
| Moving Average 200 Days | 43.21 |
| Change | -0.73 |
If you invested $1000 in Cytokinetics, Incorporated (CYTK) 10 years ago, it would be worth $5,894.91 as of July 30, 2025 at a share price of $35.9. Whereas If you bought $1000 worth of Cytokinetics, Incorporated (CYTK) shares 5 years ago, it would be worth $1,583.59 as of July 30, 2025 at a share price of $35.9.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cytokinetics to Announce Second Quarter Results On August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 8:00 PM GMT
SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 7, 2025 at 4:00 PM Eastern Time. Following the announcement, Cy
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025
GlobeNewswire Inc.
Jul 10, 2025 11:30 AM GMT
Hot Line Presentation of MAPLE-HCM to Elaborate on Positive Topline Results in Patients with Obstructive Hypertrophic Cardiomyopathy Late Breaking Clinical Science Session to Present Incidence and Impact of Atrial Fibrillation Across Three Clinical T
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
GlobeNewswire Inc.
Jun 10, 2025 11:30 AM GMT
Program to Provide Donations to Non-Profit Organizations Aligned with Corporate Values Deadline for Applications is August 4th, 2025 SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today ann